NSM Insurance Group, which is backed by The Carlyle Group, has agreed to sell its US commercial insurance unit to New Mountain Capital. No financial terms were disclosed. The deal is expected to close ...

But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. Everyone has their own methods for finding great value opportunities, but our model ...

Bluebird bio (BLUE) shares continued their downward descent Monday following news that the company plans to be taken private through a deal valued at up to $96M. Read more here.

NSM Insurance Group, a global specialty insurance provider, has signed a definitive agreement to sell its US commercial ...

Voytek Podobas, founder of Podobas Global Investments, has exited his 6% stake in Kaonavi, Inc. (4435.T), a Tokyo Stock ...

Principal Financial Group Inc. decreased its holdings in shares of The Carlyle Group Inc. (NASDAQ:CG – Free Report) by 0.7% in the 4th quarter, Holdings Channel.com reports. The institutional investor ...

Markets worldwide defied expectations in 2024 led by the dominating performance of mega-cap technology stocks known as the ...

Cash-strapped gene-therapy company Bluebird bio agreed to be acquired by private-equity firms Carlyle Group and SK Capital ...

The pioneering gene therapy developer will be acquired by investment firms Carlyle Group and SK Capital for a fraction of ...

Former NBA player Michael Carter-Williams is hoping to get a WNBA franchise in Boston whether it's through expansion a ...

Somerville gene therapy company bluebird bio, once among the highest-profile biotechs in the Boston area, has agreed to be ...